Glycerol Phenylbutyrate Patent Expiration
Glycerol Phenylbutyrate is Used for managing urea cycle disorders and nitrogen metabolism disorders. It was first introduced by Horizon Therapeutics Us Holding Llc
Glycerol Phenylbutyrate Patents
Given below is the list of patents protecting Glycerol Phenylbutyrate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Ravicti | US8404215 | Methods of therapeutic monitoring of nitrogen scavenging | Mar 09, 2032 | Horizon Therap Us |
| Ravicti | US9095559 | Methods of therapeutic monitoring of nitrogen scavenging drugs | Mar 09, 2032 | Horizon Therap Us |
| Ravicti | US10045958 | Methods of therapeutic monitoring of nitrogen scavenging drugs | Sep 22, 2030 | Horizon Therap Us |
| Ravicti | US10045959 | Methods of therapeutic monitoring of nitrogen scavenging drugs | Sep 22, 2030 | Horizon Therap Us |
| Ravicti | US10183002 | Methods of therapeutic monitoring of nitrogen scavenging drugs | Sep 22, 2030 | Horizon Therap Us |
| Ravicti | US10183003 | Methods of therapeutic monitoring of nitrogen scavenging drugs | Sep 22, 2030 | Horizon Therap Us |
| Ravicti | US10183004 | Methods of therapeutic monitoring of nitrogen scavenging drugs | Sep 22, 2030 | Horizon Therap Us |
| Ravicti | US10183005 | Methods of therapeutic monitoring of nitrogen scavenging drugs | Sep 22, 2030 | Horizon Therap Us |
| Ravicti | US10183006 | Methods of therapeutic monitoring of nitrogen scavenging drugs | Sep 22, 2030 | Horizon Therap Us |
| Ravicti | US10668040 | Treatment of urea cycle disorders in neonates and infants | Sep 22, 2030 | Horizon Therap Us |
| Ravicti | US8642012 | Methods of treatment using ammonia-scavenging drugs | Sep 22, 2030 | Horizon Therap Us |
| Ravicti | US9254278 | Methods of therapeutic monitoring of nitrogen scavenging drugs | Sep 22, 2030 | Horizon Therap Us |
| Ravicti | US9326966 | Methods of therapeutic monitoring of nitrogen scavenging drugs | Sep 22, 2030 | Horizon Therap Us |
| Ravicti | US9561197 | Methods of therapeutic monitoring of phenylacetic acid prodrugs | Sep 22, 2030 | Horizon Therap Us |
| Ravicti | US9962359 | Methods of therapeutic monitoring of nitrogen scavenging drugs | Sep 22, 2030 | Horizon Therap Us |
| Ravicti | US9999608 | Methods of therapeutic monitoring of nitrogen scavenging drugs | Sep 22, 2030 | Horizon Therap Us |
| Ravicti | US5968979 | Triglycerides and ethyl esters of phenylalkanoic acid and phenylalkenoic acid useful in treatment of various disorders |
Feb 07, 2015
(Expired) | Horizon Therap Us |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Glycerol Phenylbutyrate's patents.
Latest Legal Activities on Glycerol Phenylbutyrate's Patents
Given below is the list recent legal activities going on the following patents of Glycerol Phenylbutyrate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 30 Nov, 2023 | US10668040 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 28 Oct, 2023 | US9326966(Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 07 Aug, 2023 | US9254278(Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 03 Feb, 2023 | US9095559(Litigated) |
| Payment of Maintenance Fee, 4th Year, Large Entity | 22 Jul, 2022 | US10183002 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 22 Jul, 2022 | US10183006 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 22 Jul, 2022 | US10183003 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 22 Jul, 2022 | US10183004 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 22 Jul, 2022 | US10183005 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 14 Feb, 2022 | US10045959 |
Glycerol Phenylbutyrate's Family Patents
Explore Our Curated Drug Screens
Glycerol Phenylbutyrate Generic API Manufacturers
Only one generic application has been filed for Glycerol Phenylbutyrate.
Given below is the list of companies who have filed for Glycerol Phenylbutyrate generic, along with the locations of their manufacturing plants worldwide.
1. ENDO OPERATIONS
Endo Operations Ltd has filed for 1 generic for Glycerol Phenylbutyrate. Given below are the details of the strengths of this generic introduced by Endo Operations.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.1GM/ML | liquid | Discontinued | ORAL | N/A | Dec 2, 2021 |